News & Media :: Vedanta Biosciences, Inc.

Nov 28, 2023

Vedanta Biosciences’ Key Microbiome Patents Fully Upheld in Three European Opposition Proceedings

Recent News

Nov 13, 2023

Topline Data of Investigator-Sponsored Study of VE303 to Treat Hepatic Encephalopathy (HE) Presented at The Liver Meeting 2023

Nov 8, 2023

Microbiome treatments are taking off

Oct 30, 2023

Vedanta Biosciences to Host Investor Meetings at the Wells Fargo Virtual Private Biotech Symposium

Oct 11, 2023

Vedanta Biosciences Presents Progress from Two Defined Bacterial Consortia, VE303 for the Prevention of C. difficile and VE707 for the Prevention of Gram-Negative Infections, at IDWeek 2023

View All News View All Press Releases